Agenus (AGEN) Capital Expenditures (QoQ) (2010 - 2025)
Agenus (AGEN) Capital Expenditures (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -80.00% |
| Mar 31, 2025 | -93.15% |
| Dec 31, 2024 | 942.86% |
| Sep 30, 2024 | -98.48% |
| Jun 30, 2024 | 1,217.14% |
| Mar 31, 2024 | -84.30% |
| Dec 31, 2023 | -93.54% |
| Sep 30, 2023 | -22.20% |
| Jun 30, 2023 | 140.88% |
| Mar 31, 2023 | 146.44% |
| Dec 31, 2022 | -97.41% |
| Sep 30, 2022 | -133.42% |
| Jun 30, 2022 | 32.28% |
| Mar 31, 2022 | 141.45% |
| Dec 31, 2021 | 85.42% |
| Sep 30, 2021 | -55.29% |
| Jun 30, 2021 | 1,058.16% |
| Mar 31, 2021 | -76.50% |
| Dec 31, 2020 | -4.14% |
| Sep 30, 2020 | -42.61% |